Eloxx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CLAL INSURANCE ENTERPRISES HOLDINGS LTD | 02/13/2023 | 14,626 | $27,000 | -97.50% | 0.68% |
| JPMORGAN CHASE & CO | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CREDIT SUISSE AG/ | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 01/24/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| AMERICAN FINANCIAL GROUP INC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| ALTSHULER SHAHAM LTD | 05/09/2023 | 0 | $0 | -100.00% | 0.00% |
| MENORA MIVTACHIM HOLDINGS LTD. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 01/26/2023 | 0 | $0 | -100.00% | 0.00% |
| B. RILEY WEALTH ADVISORS, INC. | 03/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/02/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD CAPITAL WEALTH ADVISORS | 01/18/2023 | 0 | $0 | -100.00% | 0.00% |
| ATOM INVESTORS LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
Eloxx Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Eloxx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
B. Riley Wealth Management, Inc.: 37,500
Advisor Group, Inc.: 12,359
LADENBURG THALMANN FINANCIAL SERVICES INC.: 1
TIAA CREF INVESTMENT MANAGEMENT LLC: 42,529
TEACHERS ADVISORS, LLC: 40,748
0.68% of Eloxx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 133,137 shares in the last 24 months. This purchase volume represents approximately $0 in transactions.